We read with great interest the articles by Lai et al. 1 and Veldt et al. 2 , which show an association between diabetes mellitus and hepatocellular carcinoma (HCC) for patients with chronic hepatitis C. Both of their results indicate that diabetes mellitus is not significantly associated with the d
Diabetes and hepatocellular carcinoma
β Scribed by R. Palmer Beasley
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 55 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Ten percent of patients who undergo resection for hepatocellular carcinoma (HCC) associated with chronic liver disease have no detectable cause for this underlying liver disease. Recent studies have shown that patients with cryptogenic chronic liver disease frequently have risk factors for nonalcoho
We evaluated the effect of diabetes mellitus on the prognosis of hepatocellular carcinoma after an elective hepatic resection. Of the 342 patients who underwent a hepatic resection between April 1985 and March 1995, 87 (25.4%) were diabetic. Postoperative morbidity was more common among diabetics th
Immunosuppressive medications inhibit the tumor surveillance properties of the immune system. Consequently, immunosuppression may increase the likelihood of hepatocellular carcinoma (HCC) recurrence after liver transplantation. However, most data on the effects of immunosuppression on HCC recurrence